seems the executive teams for Biogen and Zosano have been meeting a lot as of late..
backfilling that empty pipeline.
apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal.
Being scooped up...
Bristol-Myers Squibb acquires Celgene for $74 billion.
Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.
Billionaire activist investor Carl Icahn has taken a sizable stake in health insurer Cigna (CI) and plans to vote against the proposed merger of Cigna with Express Scripts (ESRX), thereby threatening to scupper the entire deal...
The US Federal Trade Commission (FTC) has given its nod for the proposed $62 billion acquisition of Shire (SHPG) by Japanese firm Takeda Pharmaceuticals. The merger, the largest ever by a Japanese company, was cleared sans any conditions. Takeda plans to close the acquisition during the first...
On Monday, WSJ reported that Stryker is in talks with Boston Scientific for a potential acquisition. But today, Stryker confirmed that it didn't have any discussion with Boston Scientific. https://news.alphastreet.com/stryker-confirms-that-it-didnt-bid-for-boston-scientific/
anonymous
Thread
acquisition
boston scientific
bostonscientific
deal
healthcare
medical device
medical equipment
merger
rumor
stryker
I keep hearing little things about us possibly being acquired. Has anyone else heard this? This is coming from reliable sources. I heard it is still very early in the process, but there are talks.
If you ask Sansa Stark from HBO’s Game of Thrones, she’ll tell you the best way to go is to team up with someone strong or risk getting killed. And that’s what happens to most acquisitions in the market nowadays.
Over the past three years or so, we have seen a plethora of deal announcements...
Told you all this was going to happen. Amedicas 10k out today. Check my blog for updates as today is the start of it all! Find constant updates here and here.
https://stocktwits.com/symbol/AMDA
https://investorshub.advfn.com/Amedica-Corp-AMDA-27931/
Word on the street is that immune pharma (IMNP) is im talks to merge with a big pharma, maybe allergan. They canceled their lease and paid a significant six figure penalty to get out of it. It doesn't appear they have much of a company left, just an interim CEO to handle the transition...